Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 2
2007 1
2008 1
2009 1
2010 3
2011 4
2012 4
2013 4
2014 5
2015 1
2016 3
2017 2
2018 2
2019 1
2020 3
2021 2
2022 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
AmBisome Monotherapy and Combination AmBisome-Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial.
Burza S, Mahajan R, Kazmi S, Alexander N, Kumar D, Kumar V, Lasry E, Harshana A, de Lima Pereira A, Das P, Verma N, Das VNR, Lal CS, Rewari B, Goyal V, Rijal S, Alves F, Gill N, Pandey K. Burza S, et al. Among authors: verma n. Clin Infect Dis. 2022 Oct 12;75(8):1423-1432. doi: 10.1093/cid/ciac127. Clin Infect Dis. 2022. PMID: 35147680 Free PMC article. Clinical Trial.
Advanced case of PKDL due to delayed treatment: A rare case report.
Topno RK, Rabi Das VN, Kumar M, Madhukar M, Pandey K, Verma N, Agrawal K, Lal CS, Siddiqui NA, Bimal S, Das P. Topno RK, et al. Among authors: verma n. PLoS Negl Trop Dis. 2020 Mar 23;14(3):e0008052. doi: 10.1371/journal.pntd.0008052. eCollection 2020 Mar. PLoS Negl Trop Dis. 2020. PMID: 32203500 Free PMC article.
Ambisome plus miltefosine for Indian patients with kala-azar.
Sundar S, Sinha PK, Verma DK, Kumar N, Alam S, Pandey K, Kumari P, Ravidas V, Chakravarty J, Verma N, Berman J, Ghalib H, Arana B. Sundar S, et al. Among authors: verma n. Trans R Soc Trop Med Hyg. 2011 Feb;105(2):115-7. doi: 10.1016/j.trstmh.2010.10.008. Epub 2010 Dec 3. Trans R Soc Trop Med Hyg. 2011. PMID: 21129762
Para-kala-azar dermal Leishmaniasis cases in Indian subcontinent - A case series.
Kumar R, Das VN, Topno RK, Pal B, Imam A, Agrawal K, Singh A, Murti K, Lal CS, Verma N, Das P, Pandey K. Kumar R, et al. Among authors: verma n. Pathog Glob Health. 2016 Oct-Dec;110(7-8):326-329. doi: 10.1080/20477724.2016.1258163. Epub 2016 Nov 22. Pathog Glob Health. 2016. PMID: 27871210 Free PMC article. No abstract available.
Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India.
Goyal V, Das VNR, Singh SN, Singh RS, Pandey K, Verma N, Hightower A, Rijal S, Das P, Alvar J, Bern C, Alves F. Goyal V, et al. Among authors: verma n. PLoS Negl Trop Dis. 2020 Jul 20;14(7):e0008429. doi: 10.1371/journal.pntd.0008429. eCollection 2020 Jul. PLoS Negl Trop Dis. 2020. PMID: 32687498 Free PMC article. Clinical Trial.
A co-infection with malaria and visceral leishmaniasis in Eastern state of India.
Topno RK, Kumar R, Pandey K, Verma N, Das VR, Sahoo GC, Siddiqui NA, Sinha AK, Kumar R, Kumar R, Agrawal K, Das P. Topno RK, et al. Among authors: verma n. Presse Med. 2019 Mar;48(3 Pt 1):328-331. doi: 10.1016/j.lpm.2018.04.017. Epub 2019 Mar 8. Presse Med. 2019. PMID: 30853284 No abstract available.
Evaluation of qPCR on blood and skin microbiopsies, peripheral blood buffy coat smear, and urine antigen ELISA for diagnosis and test of cure for visceral leishmaniasis in HIV-coinfected patients in India: a prospective cohort study.
Owen SI, Burza S, Kumar S, Verma N, Mahajan R, Harshana A, Pandey K, Cloots K, Adams E, Das P. Owen SI, et al. Among authors: verma n. BMJ Open. 2021 Apr 30;11(4):e042519. doi: 10.1136/bmjopen-2020-042519. BMJ Open. 2021. PMID: 33931406 Free PMC article.
Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis.
Bhattacharya SK, Sinha PK, Sundar S, Thakur CP, Jha TK, Pandey K, Das VR, Kumar N, Lal C, Verma N, Singh VP, Ranjan A, Verma RB, Anders G, Sindermann H, Ganguly NK. Bhattacharya SK, et al. Among authors: verma n. J Infect Dis. 2007 Aug 15;196(4):591-8. doi: 10.1086/519690. Epub 2007 Jun 29. J Infect Dis. 2007. PMID: 17624846 Clinical Trial.
38 results